| Literature DB >> 28845147 |
Nils Leander Huamán-Castilla1,2, María Salomé Mariotti-Celis3, José Ricardo Pérez-Correa1.
Abstract
Carménère is the emblematic grape of Chile. Recent studies indicate that it has a different polyphenolic profile than other commercial varieties of grape among other factors, due to its long maturation period. The grape and wine of Carménère stand out for having high concentrations of anthocyanins (malvidin), flavonols (quercetin and myricetin) and flavanols (catechin, epicatechin and epigallocatechin). These compounds are related to the distinctive characteristic of Carménère wine regarding astringency and color. In vivo and in vitro models suggest some positive effects of these polyphenols in the treatment and prevention of chronic diseases, such as atherosclerosis and cancer. Therefore, there is a high level of interest to develop scalable industrial methods in order to obtain and purify Carménère grape polyphenol extracts that could be used to improve the characteristics of wines from other varieties or produce nutraceuticals or functional foods for preventing and treating various chronic diseases.Entities:
Keywords: Carménère; anthocyanins; bioactives; flavanols; flavonols; polyphenols
Year: 2017 PMID: 28845147 PMCID: PMC5543587 DOI: 10.2174/1570193X14666170206151439
Source DB: PubMed Journal: Mini Rev Org Chem ISSN: 1570-193X Impact factor: 2.495
Distribution of polyphenols in Carménère grapes.
|
|
|
|
|---|---|---|
| Skin | Anthocyanins | 42.3 |
| Flavonols | 0.3 | |
| Flavanols | 0.3 | |
| Phenolic acids | 0.1 | |
| Seed | Flavanols | 52.0 |
| Phenolic acids | 5.0 |
%: Expressed in terms of the total polyphenolic compounds found in the skin and seeds of Carménère grapes [18, 19, 22, 23].
Polyphenols content comparing CarmÉnÈre (CM) with Cabernet Sauvignon (CS).
| Description | Skin | Seed | ||
|---|---|---|---|---|
| CM | CS | CM | CS | |
| Total Polyphenols | 1.1±0.2 [ | 0.8±0.3 [ | 16.6±2.8 [ | 17.5±4.3 [ |
| Total Tannins | 2.8±0.4 [ | 3.0±0.1 [ | 32.9±3.9 [ | 36.9±9.1 [ |
| Total Anthocyanins | 0.9±0.2 [ | 0.5±0.1 [ | - - | -- |
GAE: gallic acid equivalent, ME: malvidin-3-O-glucoside equivalent.
Potential health benefits of Carménère polyphenols. Main biological effects in vitro and in vivo.
| Compounds | Potential Health Benefits | Biological Activity | References | |
|---|---|---|---|---|
|
|
| |||
| Malvidin | Cardio-Protective Effects: | Modulates myocardial and coronary performance. | [ | |
| Regulates the activity of nitrous oxide synthetase enzymes. | [ | |||
| Positive effect against lipid oxidation. | [ | [ | ||
| Anti-Inflammatory Effects: | Inhibits macrophage activation in the blood. | [ | [ | |
| Attenuates the TNF-α-induced inflammatory responses in endothelial cells. | [ | |||
| Anti-Carcinogenic Effects: | Mediate the cytotoxicity through the arrest of the G2/M phase of the cell cycle and by induction of apoptosis. | [ | ||
| Inhibited the growth of HL60 human leukemia cells through the induction of apoptosis. | [ | |||
| Myricetin | Anti-Inflammatory Effects: | Inhibits the production of pro-inflammatory mediators through the suppression of NF-κB in LPS-stimulated RAW264.7 macrophages. | [ | |
| Anti-Carcinogenic Effects: | Exerts potent anti-proliferative and pro-apoptotic effects on K562 human leukemia cells. | [ | ||
| Bone Effects: | Inhibits osteoclast formation, and shows an effect in preventing alveolar bone loss. | [ | [ | |
| Quercetin | Anti-Allergenic Effects: | Inhibits the release of histamine, IgE-mediated. | [ | |
| Anti-Inflammatory Effects: | Antioxidant and protective effect against gastric ulceration. | [ | ||
| Ability to suppress NO production in LPS-stimulated macrophage RAW 264.7 cells. | [ | |||
| Interact synergistically with resveratrol contributing to counteract inflammation of the skin, and resulting in tissue repair and wound healing. | [ | |||
| Anti-Carcinogenic Effects: | Inhibits cell growth and induction of apoptosis in H460, A549 and H1299 lung cancer cells. | [ | ||
| Inhibits the growth of HCT116 cancer cells which caused apoptosis in the cells. | [ | |||
| Interact synergistically with resveratrol and ellagic acid in the induction of apoptosis and reduction of cell growth in human leukemia cells (MOLT-4). | [ | |||
| Epigallocatechin | Anti-Carcinogenic Effects: | Inhibits strongly the growth of breast cancer cell lines (MCF-7 and MDA-MB-231) due to an induction of apoptosis. | [ | |
| Bone Effects: | Effective in promoting osteogenic differentiation in bone formation. | [ | ||